Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 20/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22804201 | 0.95 | EGFR (0.75) | EGFR | |
| SCHEMBL22025902 | 0.93 | EGFR (0.81) | EGFR | |
| SCHEMBL28531463 | 0.92 | EGFR (0.71) | EGFR | |
| SCHEMBL29117520 | 0.91 | EGFR (0.70) | EGFR | |
| SCHEMBL22595549 | 0.90 | EGFR (0.68) | EGFR | |
| SCHEMBL28536163 | 0.90 | EGFR (0.71) | EGFR | |
| SCHEMBL28536305 | 0.90 | EGFR (0.71) | EGFR | |
| SCHEMBL28530838 | 0.90 | EGFR (0.72) | EGFR | |
| SCHEMBL22804167 | 0.90 | EGFR (0.81) | EGFR | |
| SCHEMBL28527684 | 0.90 | EGFR (0.70) | EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022012622-A1 | DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BEIGENE, LTD. (KY) | 2022-01-20 | — | — | WO | disclosed |
| WO-2022012623-A1 | DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BEIGENE, LTD. (KY) | 2022-01-20 | — | — | WO | disclosed |